Hyaluronic Acid
In clinical developmentAlso known as Amvisc, Healon, Hyaluronan, Hymovis+2 more
Amvisc, Healon, Hyaluronan, Hymovis, Orthovisc, hyaluronic acid, hydrolyzed.
Recent clinical, regulatory, research and industry developments relating to this drug.
Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis
Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study
Skin boosters: Definitions and varied classifications.
The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.
A review of current advancements for wound healing: Biomaterial applications and medical devices.
Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons2
- Biomolecules1
- Cells1
- International journal of molecular sciences1
- Journal of biomedical materials research. Part B, Applied biomaterials1
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
- Aghaloo T2
- Bouloux GF2
- Chou J2
- Giannakopoulos H2
- Kahenasa N2
- Krishnan D2
- Smith JA2
- Abatangelo G1
- Clinical Assistant Professor2
- Emory University School of Medicine2
- Oregon Health and Science University2
- University Buffalo New York2
- University of California-Los Angeles2
- University of Cincinnati2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Hyaluronic Acid in the shared literature.
Studied across 5 of the same disease areas as Hyaluronic Acid in the shared literature.
Studied across 5 of the same disease areas as Hyaluronic Acid in the shared literature.
Studied across the same disease area as Hyaluronic Acid in the shared literature.
Studied across the same disease area as Hyaluronic Acid in the shared literature.
Frequently co-studied with Hyaluronic Acid in the research literature.
Frequently co-studied with Hyaluronic Acid in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials